Buspar use in patients with impaired hepatic or renal function precautions
Buspar is metabolized by the liver and excreted by the kidneys. A pharmacokinetic study in patients with impaired hepatic or renal function demonstrated increased plasma levels and a lengthened half-life of Buspar. Therefore, the administration of BuSpar to patients with severe hepatic or renal impairment cannot be recommended.
Click here to order Buspar, U.S. orders only
Related posts:
Categories: Buspar
